secwatch.observer — SEC 8-K summary
======================================

Issuer:     CytoDyn Inc. (CYDY)
CIK:        0001175680
Form:       8-K
Filed at:   2024-01-29T23:59:59+00:00
Accession:  0001558370-24-000603
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CytoDyn appoints Jacob Lalezari as permanent CEO, names Mitchell Cohen interim CFO
--------------------------------------------------------------------------------

- Jacob Lalezari appointed CEO effective Jan 26, 2024; previously interim CEO since Nov 2023.
- Base salary $400K, target annual bonus 40%, option grant of 3M shares vesting over 4 years.
- Antonio Migliarese resigns as CFO effective Jan 31, 2024; last day Feb 15.
- Mitchell Cohen appointed interim CFO effective Feb 1, 2024; independent contractor via Rapid Deployment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175680/000155837024000603/0001558370-24-000603-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175680/000155837024000603/cydy-20240123x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-000603

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer